Olopatadine Hydrochloride (Apotex Corp.)
Welcome to the PulseAid listing for the Olopatadine Hydrochloride drug offered from Apotex Corp.. This Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Apotex Corp. |
NON-PROPRIETARY NAME: | olopatadine hydrochloride |
SUBSTANCE NAME: | OLOPATADINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Histamine Release [PE],Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |
ROUTE: | NASAL |
DOSAGE FORM: | SPRAY, METERED |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2014-10-27 |
END MARKETING DATE: | 0000-00-00 |
Olopatadine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Olopatadine Hydrochloride from Apotex Corp. |
LABELER NAME: | Apotex Corp. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 665(ug/1) |
START MARKETING DATE: | 2014-10-27 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 60505-0845_255fefaa-5e06-2a06-600d-2dbf6e11ac2c |
PRODUCT NDC: | 60505-0845 |
APPLICATION NUMBER: | ANDA091572 |
Other OLOPATADINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: